{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:44:38Z","timestamp":1789868678517,"version":"4.0.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T00:00:00Z","timestamp":1615680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100015391","name":"Myositis Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Idiopathic inflammatory myopathies (IIMs) cause proximal muscle weakness, which affects the ability to carry out the activities of daily living. Wearable physical activity monitors (PAMs) objectively assess continuous activity and potentially have clinical usefulness in the assessment of IIMs. We examined the psychometric characteristics for PAM outcomes in IIMs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Adult IIM patients were prospectively evaluated (at baseline, 3\u2009months and 6\u2009months) in an observational study. A waist-worn PAM (ActiGraph GT3X-BT) assessed average step counts\/minute, peak 1-minute cadence, and vector magnitude\/minute. Validated myositis core set measures (CSMs) including manual muscle testing (MMT), physician global disease activity (MD global), patient global disease activity (Pt global), extramuscular disease activity (Ex-muscular global), HAQ-DI (HAQ disability index), muscle enzymes, and patient-reported physical function were evaluated. Test\u2013retest reliability, construct validity, and responsiveness were determined for PAM measures and CSMs, using Pearson correlations and other appropriate analyses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 50 adult IIM patients enrolled [mean (s.d.) age, 53.6 (14.6); 60% female, 94% Caucasian]. PAM measures showed strong test\u2013retest reliability, moderate-to-strong correlations at baseline with MD global (r = \u22120.37 to \u22120.48), Pt global (r=\u22120.43 to \u22120.61), HAQ-DI (r\u2009=\u2009\u22120.47 to \u22120.59) and MMT (r\u2009=\u20090.37\u20130.52), and strong discriminant validity for categorical MMT and HAQ-DI. Longitudinal associations with MD global (r=\u22120.38 to \u22120.44), MMT (r\u2009=\u20090.50\u20130.57), HAQ-DI (r\u2009=\u2009\u22120.45 to \u22120.55) and functional tests (r\u2009=\u20090.30\u20130.65) were moderate to strong. PAM measures were responsive to MMT improvement \u226510% and moderate-to-major improvement on ACR\/EULAR myositis response criteria. Peak 1-minute cadence had the largest effect size and standardized response means.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>PAM measures showed promising construct validity, reliability, and longitudinal responsiveness; especially peak 1-minute cadence. PAMs are able to provide valid outcome measures for future use in IIM clinical trials.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab236","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T20:10:50Z","timestamp":1615579850000},"page":"5713-5723","source":"Crossref","is-referenced-by-count":26,"title":["Reliability, validity and responsiveness of physical activity monitors in patients with inflammatory myopathy"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4096-917X","authenticated-orcid":false,"given":"Bonny","family":"Rockette-Wagner","sequence":"first","affiliation":[{"name":"Department of Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didem","family":"Saygin","sequence":"additional","affiliation":[{"name":"Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siamak","family":"Moghadam-Kia","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester","family":"Oddis","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oc\u00e9ane\u00a0","family":"Landon-Cardinal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology and Inflammation-Immunopathology-Biotherapy Department (I2B), Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Assistance Publique-H\u00f4pitaux de Paris, East Paris Neuromuscular Diseases Reference Center, Inserm U974, Sorbonne Universit\u00e9, Paris, France"},{"name":"Division of Rheumatology and Research Center, Department of Medicine, University of Montr\u00e9al, Centre Hospitalier de L\u2019Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Allenbach","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology and Inflammation-Immunopathology-Biotherapy Department (I2B), Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Assistance Publique-H\u00f4pitaux de Paris, East Paris Neuromuscular Diseases Reference Center, Inserm U974, Sorbonne Universit\u00e9, Paris, France"},{"name":"Institute of Myology, Neuromuscular Investigation Center, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedin","family":"Dzanko","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Koontz","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Neiman","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,14]]},"reference":[{"key":"2021121823180725100_keab236-B1","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1517\/14656560902913815","article-title":"Treatment of the inflammatory myopathies: update and practical recommendations","volume":"10","author":"Hengstman","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"2021121823180725100_keab236-B2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1600-0404.2011.01584.x","article-title":"Prognosis and prognostic factors in sporadic inclusion body myositis","volume":"125","author":"Lindberg","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"2021121823180725100_keab236-B3","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/ard.2005.045690","article-title":"Long-term outcome in polymyositis and dermatomyositis","volume":"65","author":"Bronner","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2021121823180725100_keab236-B4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/rheumatology\/keh404","article-title":"Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis","volume":"44","author":"Ponyi","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"2021121823180725100_keab236-B5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/rheumatology\/keq356","article-title":"Patients with polymyositis or dermatomyositis have reduced grip force and health-related quality of life in comparison with reference values: an observational study","volume":"50","author":"Regardt","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2021121823180725100_keab236-B6","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1002\/art.24904","article-title":"Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index","volume":"60","author":"Rider","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2021121823180725100_keab236-B7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/bmj.289.6438.151","article-title":"Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease","volume":"289","author":"Bernstein","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2021121823180725100_keab236-B8","first-page":"S404","article-title":"A consensus hybrid definition using a conjoint analysis is proposed as response criteria for minimal and moderate improvement in adult polymyositis and dermatomyositis clinical trials","volume":"66","author":"Aggarwal","year":"2014","journal-title":"Arthritis Rheum"},{"key":"2021121823180725100_keab236-B9","first-page":"240","article-title":"Defining clinically relevant changes in core set activity measures for adult and juvenile idiopathic inflammatory myopathies (IIM","volume":"63","author":"Rider","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2021121823180725100_keab236-B10","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/01.cir.0000435708.67487.da","article-title":"Guide to the assessment of physical activity: clinical and research applications: a scientific statement from the American Heart Association","volume":"128","author":"Strath","year":"2013","journal-title":"Circulation"},{"key":"2021121823180725100_keab236-B11","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s40279-016-0663-1","article-title":"Step counting: a review of measurement considerations and health-related applications","volume":"47","author":"Bassett","year":"2017","journal-title":"Sports Med"},{"key":"2021121823180725100_keab236-B12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pmedr.2015.12.005","article-title":"Bouted and non-bouted moderate-to-vigorous physical activity with health-related quality of life","volume":"3","author":"Loprinzi","year":"2016","journal-title":"Prev Med Rep"},{"key":"2021121823180725100_keab236-B13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s41687-019-0136-z","article-title":"Patient reported outcomes can improve performance status assessment: a pilot study","volume":"3","author":"Broderick","year":"2019","journal-title":"J Patient Rep Outcomes"},{"key":"2021121823180725100_keab236-B14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13030-015-0046-0","article-title":"Physical activity of elderly patients with rheumatoid arthritis and healthy individuals: an actigraphy study","volume":"9","author":"Hashimoto","year":"2015","journal-title":"Biopsychosoc Med"},{"key":"2021121823180725100_keab236-B15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/acr.20369","article-title":"Defining quality of care in rheumatology: the American College of Rheumatology white paper on quality measurement","volume":"63","author":"Saag","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021121823180725100_keab236-B16","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/acr.22936","article-title":"American College of Rheumatology white paper on performance outcome measures in Rheumatology","volume":"68","author":"Suter","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021121823180725100_keab236-B17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2021121823180725100_keab236-B18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2021121823180725100_keab236-B19","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/art.1780401109","article-title":"Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group","volume":"40","author":"Rider","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2021121823180725100_keab236-B20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1123\/jpah.2011-0347","article-title":"Detection of physical activity types using triaxial accelerometers","volume":"11","author":"Skotte","year":"2014","journal-title":"J Phys Act Health"},{"key":"2021121823180725100_keab236-B21","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1249\/MSS.0b013e31820ce174","article-title":"Validation of wearable monitors for assessing sedentary behavior","volume":"43","author":"Kozey-Keadle","year":"2011","journal-title":"Med Sci Sports Exerc"},{"key":"2021121823180725100_keab236-B22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/02701367.2000.10608878","article-title":"Assessment of physical activity with the Computer Science and Applications, Inc., accelerometer: laboratory versus field validation","volume":"71","author":"Nichols","year":"2000","journal-title":"Res Q Exerc Sport"},{"key":"2021121823180725100_keab236-B23","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1123\/jpah.2011-0167","article-title":"Relative validity of 3 accelerometer models for estimating energy expenditure during light activity","volume":"11","author":"Wetten","year":"2014","journal-title":"J Phys Act Health"},{"key":"2021121823180725100_keab236-B24","doi-asserted-by":"crossref","first-page":"S442","DOI":"10.1097\/00005768-200009001-00002","article-title":"Validity of accelerometry for the assessment of moderate intensity physical activity in the field","volume":"32","author":"Hendelman","year":"2000","journal-title":"Med Sci Sports Exerc"},{"key":"2021121823180725100_keab236-B25","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1183\/09031936.00134312","article-title":"Validity of physical activity monitors during daily life in patients with COPD","volume":"42","author":"Rabinovich","year":"2013","journal-title":"Eur Respir J"},{"key":"2021121823180725100_keab236-B26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jsams.2011.04.003","article-title":"Validation and comparison of ActiGraph activity monitors","volume":"14","author":"Sasaki","year":"2011","journal-title":"J Sci Med Sport"},{"key":"2021121823180725100_keab236-B27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.amepre.2009.01.021","article-title":"Translating physical activity recommendations into a pedometer-based step goal: 3000 steps in 30 minutes","volume":"36","author":"Marshall","year":"2009","journal-title":"Am J Prev Med"},{"key":"2021121823180725100_keab236-B28","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1249\/MSS.0b013e318258cb36","article-title":"Assessment of wear\/nonwear time classification algorithms for triaxial accelerometer","volume":"44","author":"Choi","year":"2012","journal-title":"Med Sci Sports Exerc"},{"key":"2021121823180725100_keab236-B29","doi-asserted-by":"crossref","first-page":"S531","DOI":"10.1249\/01.mss.0000185657.86065.98","article-title":"Conducting accelerometer-based activity assessments in field-based research","volume":"37","author":"Trost","year":"2005","journal-title":"Med Sci Sports Exerc"},{"key":"2021121823180725100_keab236-B30","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1136\/bmj.284.6329.1607","article-title":"Two-, six-, and 12-minute walking tests in respiratory disease","volume":"284","author":"Butland","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2021121823180725100_keab236-B31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"The timed \u201cUp & Go\u201d: a test of basic functional mobility for frail elderly persons","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"2021121823180725100_keab236-B32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1743-0003-11-83","article-title":"Timed Up & Go as a measure for longitudinal change in mobility after stroke \u2013 Postural Stroke Study in Gothenburg (POSTGOT)","volume":"11","author":"Persson","year":"2014","journal-title":"J Neuroeng Rehabil"},{"key":"2021121823180725100_keab236-B33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/annrheumdis-2013-204053","article-title":"Responsiveness and minimally important difference for the patient-reported outcomes measurement information system (PROMIS) 20-item physical functioning short form in a prospective observational study of rheumatoid arthritis","volume":"74","author":"Hays","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021121823180725100_keab236-B34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12603-009-0010-4","article-title":"The SF-36: a simple, effective measure of mobility-disability for epidemiological studies","volume":"13","author":"Syddall","year":"2009","journal-title":"J Nutr Health Aging"},{"key":"2021121823180725100_keab236-B35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1212\/WNL.0000000000004061","article-title":"Physical activity monitoring: a promising outcome measure in idiopathic inflammatory myopathies","volume":"89","author":"Bachasson","year":"2017","journal-title":"Neurology"},{"key":"2021121823180725100_keab236-B36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol Bull"},{"key":"2021121823180725100_keab236-B37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4300\/JGME-D-12-00156.1","article-title":"Using effect size\u2014or why the P value is not enough","volume":"4","author":"Sullivan","year":"2012","journal-title":"J Grad Med Educ"},{"key":"2021121823180725100_keab236-B38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/jnnp.57.Suppl.50","article-title":"Indications for intravenous gammaglobulin therapy in inflammatory myopathies","volume":"57(Suppl","author":"Cherin","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2021121823180725100_keab236-B39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-92-3-365","article-title":"Azathioprine with prednisone for polymyositis. A controlled, clinical trial","volume":"92","author":"Bunch","year":"1980","journal-title":"Ann Intern Med"},{"key":"2021121823180725100_keab236-B40","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/rheumatology\/kex226","article-title":"2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria\u2014methodological aspects","volume":"56","author":"Rider","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2021121823180725100_keab236-B41","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"2021121823180725100_keab236-B42","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1249\/MSS.0b013e3181e32d7f","article-title":"Accelerometer-determined steps per day in US children and youth","volume":"42","author":"Tudor-Locke","year":"2010","journal-title":"Med Sci Sports Exerc"},{"key":"2021121823180725100_keab236-B43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1249\/mss.0b013e31815a51b3","article-title":"Physical activity in the United States measured by accelerometer","volume":"40","author":"Troiano","year":"2008","journal-title":"Med Sci Sports Exerc"},{"key":"2021121823180725100_keab236-B44","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/annrheumdis-2017-211400","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: an International Myositis Assessment and Clinical Studies Group\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative","volume":"76","author":"Aggarwal","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021121823180725100_keab236-B45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s41927-019-0088-1","article-title":"A review of accelerometer-derived physical activity in the idiopathic inflammatory myopathies","volume":"3","author":"Oldroyd","year":"2019","journal-title":"BMC Rheumatol"},{"key":"2021121823180725100_keab236-B46","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.semarthrit.2016.03.010","article-title":"Physical (in)activity and its influence on disease-related features, physical capacity, and health-related quality of life in a cohort of chronic juvenile dermatomyositis patients","volume":"46","author":"Pinto","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2021121823180725100_keab236-B47","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.semarthrit.2020.06.014","article-title":"Relationship between change in physical activity and in clinical status in patients with idiopathic inflammatory myopathy: a prospective cohort study","volume":"50","author":"Landon-Cardinal","year":"2020","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"2021121823180725100_keab236-B48","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1249\/JES.0000000000000206","article-title":"A framework to evaluate devices that assess physical behavior","volume":"47","author":"Keadle","year":"2019","journal-title":"Exerc Sport Sci Rev"},{"key":"2021121823180725100_keab236-B49","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1249\/MSS.0000000000000215","article-title":"Reactivity to accelerometer measurement of children and adolescents","volume":"46","author":"Dossegger","year":"2014","journal-title":"Med Sci Sports Exerc"},{"key":"2021121823180725100_keab236-B50","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1123\/jpah.8.5.668","article-title":"Accelerometer test\u2013retest reliability by data processing algorithms: results from the Twin Cities Walking Study","volume":"8","author":"Sirard","year":"2011","journal-title":"J Phys Activity Health"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab236\/37803114\/keab236.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/12\/5713\/41820297\/keab236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/12\/5713\/41820297\/keab236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T23:26:09Z","timestamp":1639869969000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/12\/5713\/6170650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,14]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,3,14]]},"published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab236","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,3,14]]}}}